Table 3.
Comparing functional and anatomical response in different diseases
| Variables | nAMD (N=50) | DMO (N=37) | RVO (N=30) | P value* |
| ≥5 ETDRS letters increase (%) | 31 (62) | 12 (32) | 21 (70) | 0.003† |
| ≥15 ETDRS letters increase (%) | 16 (32) | 2 (5) | 13 (43) | <0.005‡ |
| ≥10% decrease in CMT (%) | 27 (54) | 24 (65) | 23 (77) | 0.122 |
Data are presented as the number of individuals and corresponding percentages.
*Global p values testing for a difference between any of the diseases with a χ2 test are given. For comparisons that are significant at the global level, adjusted pairwise p values for individual study comparisons are reported. Significant p values are in bold.
†nAMD vs DMO p<0.05; DMO vs RVO p<0.05; nAMD vs RVO p>0.05.
‡nAMD vs DMO p<0.05; DMO vs RVO p<0.05; nAMD vs RVO p>0.05.
CMT, central macular thickness; DMO, diabetic macular oedema; ETDRS, early treatment diabetic retinopathy study; nAMD, neovascular age-related macular degeneration; RVO, retinal vein occlusion.